Orexin signaling in the VTA gates morphine-induced synaptic plasticity

Journal of Neuroscience

Volumn 35, Issue 18, 2015, Pages 7295-7303

  Baimel, Corey ^a,b   Borgland, Stephanie L ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

AMPA; Dopamine; Morphine; NMDA; Orexin; Ventral tegmental area

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1, 5 NAPHTHYRIDIN 4 YL) UREA; 4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; BIOCYTIN; FLUORESCEIN ISOTHIOCYANATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OREXIN 1 RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; NEUROPEPTIDE; OREXIN RECEPTOR; OREXINS; SIGNAL PEPTIDE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG INFUSION; EXCITATION AND STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GLUTAMATERGIC SYNAPSE; INHIBITORY POSTSYNAPTIC POTENTIAL; INTRACELLULAR SIGNALING; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NONHUMAN; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM; WHOLE CELL PATCH CLAMP; ANIMAL; DRUG EFFECTS; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; DOPAMINERGIC NEURONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MORPHINE; NEURONAL PLASTICITY; NEUROPEPTIDES; OREXIN RECEPTORS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VENTRAL TEGMENTAL AREA;

EID: 84929359359     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4385-14.2015     Document Type: Article

References (50)

1. Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L (2007) Neural substrates of awakening probed with optogenetic control ofhypo-cretin neurons. Nature 450:420-424. CrossRef Medline
2. Argilli E, Sibley DR, Malenka RC, England PM, Bonci A (2008) Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci 28:9092-9100. CrossRef Medline
3. Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL (2015) Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 172:334-348. CrossRef Medline
4. Borgland SL, Malenka RC, Bonci A (2004) Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 24:7482-7490. CrossRef Medline
5. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA Is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601. CrossRef Medline
6. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A (2009) Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29:11215-11225. CrossRef Medline
7. Brown MT, Bellone C, Mameli M, Labouèbe G, Bocklisch C, Balland B, Dahan L, Luján R, Deisseroth K, Lüscher C (2010) Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation PLoS One 5:el5870. CrossRef Medline
8. Burlet S, Tyler CJ, Leonard CS (2002) Direct and indirect excitation of lat-erodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22:2862-2872. Medline
9. Carlezon WA Jr, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ (1997) Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812-814. CrossRef Medline
10. Dacher M, Nugent FS (2011) Morphine-induced modulation of LTD at GABAergic synapses in the ventral tegmental area. Neuropharmacology 61:1166-1171. CrossRef Medline
11. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natì Acad Sci U S A 95: 322-327. CrossRef Medline
12. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080. Medline
13. Engblom D, Bilbao A, Sanchis-Segura C, Dahan L, Perreau-Lenz S, Balland B, Parkitna JR, Luján R, Halbout B, Mameli M, Parlato R, Sprengel R, Lüscher C, Schütz G, Spanagel R (2008) Glutamate receptors on dopamine neurons control the persistence of cocaine seeking. Neuron 59:497-508. CrossRef Medline
14. España RA, Melchior JR, Roberts DCS, Jones SR (2010) Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 214:415-426. CrossRef Medline
15. Floresco SB, West AR, Ash B, Moore H, Grace AA (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968-973. CrossRef Medline
16. Gantz SC, Bunzow JR, Williams JT (2013) Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor. Neuron 78:807-812. CrossRef Medline
17. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanag-isawa M, Nestler EJ, DiLeone RJ (2003) Involvement of the lateral hy-pothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106-3111. Medline
18. Graziane NM, Polter AM, Briand LA, Pierce RC, Kauer JA (2013) Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron 77:942-954. CrossRef Medline
19. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556-559. CrossRef Medline
20. Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G (2007) Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 183: 43-51. CrossRef Medline
21. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565-598. CrossRef Medline
22. Jalabert M, Bourdy R, Courtin J, Veinante P, Manzoni OJ, Barrot M, Georges F (2011) Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci USA 108:16446-16450. CrossRef Medline
23. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488. Medline
24. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858. CrossRef Medline
25. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23:7-11. Medline
26. Lambe EK, Aghajanian GK (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical bou-tons in prefrontal slice. Neuron 40:139-150. CrossRef Medline
27. Li Y, van den Pol AN (2008) μ-Opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. J Neurosci 28:2814-2819. CrossRef Medline
28. Li Y, Gao XB, Sakurai T, van den Pol AN (2002) Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36:1169-1181. CrossRef Medline
29. Lüscher C, Ungless MA (2006) The mechanistic classification of addictive drugs. PLoS Med 3:e437. CrossRef Medline
30. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6-25. CrossRef Medline
31. NaritaM, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26:398-405. CrossRef Medline
32. Narita M, Nagumo Y, Miyatake M, Ikegami D, Kurahashi K, Suzuki T (2007) Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur J Neurosci 25:1537-1545. CrossRef Medline
33. Niehaus JL, Murali M, Kauer JA (2010) Drugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area. Eur J Neurosci 32:108-117. CrossRef Medline
34. Nugent FS, Penick EC, Kauer JA (2007) Opioids block long-term potentiation of inhibitory synapses. Nature 446:1086-1090. CrossRef Medline
35. Rao Y, Mineur YS, Gan G, Wang AH, Liu ZW, Wu X, Suyama S, de Lecea L, Horvath TL, Picciotto MR, Gao XB (2013) Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice. J Physiol 591: 1951-1966. CrossRef Medline
36. Richardson KA, Aston-Jones G (2012) Lateral hypothalamic orexin/ hypocretin neurons that project to the ventral tegmental area are differentially activated with morphine preference. J Neurosci 32:3809-3817. CrossRef Medline
37. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582. CrossRef Medline
38. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585. CrossRef Medline
39. Sarti F, Zhang Z, Schroeder J, Chen L (2013) Rapid suppression of inhibitory synaptic transmission by retinoic acid. J Neurosci 33:11440-11450. CrossRef Medline
40. Schilström B, Yaka R, Argilli E, SuvarnaN, Schumann J, Chen BT, Carman M, Singh V, Mailliard WS, Ron D, Bonci A (2006) Cocaine enhances NMDA receptor-mediated currents in the ventral tegmental area vid dopamine D5 receptor-dependent redistribution of NMDA receptors. J Neurosci 26:8549-8558. CrossRef Medline
41. Smith BN, Davis SF, Van Den Pol AN, Xu W (2002) Selective enhancement of excitatory synaptic activity in the rat nucelus tractus solitarius by hypocretin 2. Neuroscience 115:707-714. CrossRef Medline
42. Smith RJ, Aston-Jones G (2012) Orexin/hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 35:798-804. CrossRef Medline
43. Thompson JL, Borgland SL (2013) Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons. Biol Psychiatry 73:860-868. CrossRef Medline
44. Trivedi P, Yu H, MacNeil DJ, Van der Poeg LH, Guan XM (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438:71-75. CrossRef Medline
45. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411:583-587. CrossRef Medline
46. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18:7962-7971. Medline
47. Vittoz NM, Berridge CW (2006) Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 31:384-395. CrossRef Medline
48. Vittoz NM, Schmeichel B, Berridge CW (2008) Hypocretin/orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur J Neurosci 28:1629-1640. CrossRef Medline
49. Yeoh JW, James MH, Jobling P, Bains JS, Graham BA, Dayas CV (2012) Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus. J Physiol 590:3677-3689. CrossRef Medline
50. Zheng F, Johnson SW (2001) Glycine receptor-mediated inhibition of dopamine and nondopamine neurons of the rat ventral tegmental area in vitro. Brain Res 919:313-317. CrossRef Medline